Perspectify News
31 minutes ago
The most trusted news from Asia and the Pacific
Provided by AGP
AGP Picks
View all
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
5 hours ago
Mountain-Pacific Quality Health
As featured in:
@ Journalists!
Join
Press releases
Publish your press release
May. 8, 2026
Xiaohong (Sharon) Chen named Business Director, Asia Pacific at the Federal Transnational Consortium of Commerce Group
EIN Presswire
MANHATTAN, NY, UNITED STATES, May 8, 2026 /EINPresswire.com/ -- The Federal Transnational Consortium of Commerce Group (FTCOC) continues expanding its international commerce and peace driven initiatives, focused on connecting Chinese enterprises...
May. 8, 2026
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire, Inc.
SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating...
May. 8, 2026
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no patients relapsing or requiring...
May. 8, 2026
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
GlobeNewswire, Inc.
Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no patients relapsing or requiring new...
May. 8, 2026
The Artery Stenosis Drug Market is projected to grow to $3.46 billion by 2030, expanding at a 5.9% compound growth rate.
EIN Presswire
The Business Research Company’s Artery Stenosis Drug Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2026 /EINPresswire.com/ -- The artery stenosis drug market has witnessed...
May. 6, 2026
Asia Pacific Chemical (Tianjin) Expands Global Distribution as Leading Titanium Dioxide Supplier
EIN Presswire
JINNAN, TIANJIN, CHINA, May 6, 2026 /EINPresswire.com/ -- In the complex architecture of modern industrial manufacturing, Titanium Dioxide (TiO2) serves as an indispensable component.
Video Stories
Discover Affinity Group Publishing
Sign up for:
Asia News Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
